Patent US4192860A successfully refreshed from Google Patents.
US4192860A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Methods for treating disease conditions
Assignee: Fisons Ltd
•
Filing: 1978-04-27
•
Granted: 1980-03-11
•
Expires: 1998-04-27
Abstract
Abstract There is described a method for the prophylactic or curative treatment of a disease condition having an allergic basis in cats, dogs or horses or a condition of the respiratory tract having an allergic basis in cattle which comprises administering an active ingredient having sodium cromoglycate like activity to an animal suffering, or liable to suffer, from such a condition. There are also described compositions and mixtures for use in the treatment of the animals.
Inventors
- 👤 Alan J. Griffiths
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-24 19:45
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/335; A61K31/35
Claims Analysis
Total Claims: 13
Claim 1
Independent Claim
122 words
A method for curative treatment of a disease condition in cats, dogs horses or cattle as follows: (a) in horses: broken wind, heaves, chronic pulmonary disease, laminitis or sweat itch; (b) in cattle: fog fever, husk, acute bovine pulmonary emphysema, bovine farmer's lung and respiratory diseases due to Respiratory Syncytial Bovine Virus; (c) in cats or dogs: allergic condition produced in response to allergens present in foods or food additives, in therapeutic agents, in parasitic fungi, produced by bacterial or fungal infection, or as a response to inhaled or contact antigens; which method comprises administering an effective amount of an active ingredient having sodium cromoglycate like activity to cattle or to a horse, pig, cat or dog suffering from such a condition.
Claim 2
Independent Claim
122 words
A method for curative treatment of a disease condition in cats, dogs horses or cattle as follows: (a) in horses: broken wind, heaves, chronic pulmonary disease, laminitis or sweat itch; (b) in cattle: fog fever, husk, acute bovine pulmonary emphysema, bovine farmer's lung and respiratory diseases due to Respiratory Syncytial Bovine Virus; (c) in cats or dogs: allergic condition produced in response to allergens present in foods or food additives, in therapeutic agents, in parasitic fungi, produced by bacterial or fungal infection, or as a response to inhaled or contact antigens; which method comprises administering an effective amount of an active ingredient having sodium cromoglycate like activity to cattle or to a horse, pig, cat or dog suffering from such a condition.
Claim 3
Dependent Claim
45 words
A method according to claim 1 wherein the active ingredient is a compound of formula I, ##STR2## wherein X is a polymethylene chain containing 3 to 7 carbon atoms inclusive, which chain may be substituted by an --OH group, or a pharmaceutically acceptable salt thereof.
Claim 4
Dependent Claim
13 words
A method according to claim 1, wherein the active ingredient is sodium cromoglycate.
Claim 5
Dependent Claim
29 words
A method according to claim 1, wherein the condition is a pulmonary condition in the horse or in cattle in which allergy or immune reactions play a contributory part.
Claim 6
Dependent Claim
22 words
A method according to claim 1, wherein broken wind, heaves, chronic pulmonary disease, laminitis or sweat itch, is treated in a horse.
Claim 7
Dependent Claim
31 words
A method according to claim 1, wherein fog fever, husk, acute bovine pulmonary emphysema, bovine farmer's lung or a respiratory disease due to Respiratory Syncytial Bovine Virus is treated in cattle.
Claim 8
Dependent Claim
50 words
A method according to claim 1, wherein an allergic condition produced as a response to allergens contained in foods and food additives, in therapeutic agents, in parasitic fungi, produced by bacterial or fungal infection, or as a response to inhaled or contact antigens is treated in a cat or dog.
Claim 9
Dependent Claim
22 words
A method according to claim 1, wherein the active ingredient is administered directly to the respiratory tract, the gut or the skin.
Claim 10
Dependent Claim
29 words
A method according to claim 1, wherein the condition is of the respiratory tract and the active ingredient is administered as a nebulised solution or as a powder aerosol.
Claim 11
Dependent Claim
31 words
A method according to claim 1, wherein the active ingredient is administered intravenously, intramuscularly or subcutaneously at a dosage of from 5 to 15 mg per kg of animal body weight.
Claim 12
Dependent Claim
18 words
A method according to claim 1, wherein a dosage of 40 to 160 mg is administered by inhalation.
Claim 13
Dependent Claim
26 words
A method according to claim 1, wherein a daily dosage of from 25 to 250 mg of active ingredient is administered to a cat or dog.
References Cited (Backward Citations)
US3419578A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1983-03-11 | 1983-09-10 | 1984-03-11 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1987-03-11 | 1987-09-10 | 1988-03-11 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1991-03-11 | 1991-09-10 | 1992-03-11 | $7700.00 | Window Closed / Lapsed |